BioSpace News Archive

Janssen will present data from the trial at a September conference in Stockholm. The company plans to seek FDA approval later this year.

As technology is ever-evolving, it stands to reason that many of the jobs in the pharma industry today will also change as the pages of the calendar flip.

The PIIO will build upon current immuno-oncology efforts that are already underway at the OSUCCC – James, including the treatment of a variety of cancers with immunotherapies.

The research could have broad implications in treating age-related illnesses, as well as cancer prevention.

A recent study conducted by the Milbank Quarterly found that the FDA followed the guidelines of the scientific advisory committees 78% of the time. To come to that conclusion, researchers examined public documents from FDA advisory committee meetings and medical product databases for all FDA advisory committee meetings from 2008 through 2015.

Sales of Humira slid in Europe as AbbVie’s cash cow continues to face competition from biosimilars that became available at the end of last year.

Nektar noted that the delay is not due to an issue with its novel opioid formulation, but rather with new policies regarding opioids being implemented at the FDA.